Michael Sinclair - Net Worth and Insider Trading

Michael Sinclair Net Worth

The estimated net worth of Michael Sinclair is at least $396,893 dollars as of 2024-04-25. Michael Sinclair is the Director, 10% Owner of Opiant Pharmaceuticals Inc and owns about 19,220 shares of Opiant Pharmaceuticals Inc (OPNT) stock worth over $396,893. Details can be seen in Michael Sinclair's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Michael Sinclair has not made any transactions after 2022-06-15 and currently still holds the listed stock(s).

Transaction Summary of Michael Sinclair

To

Michael Sinclair Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Michael Sinclair owns 1 companies in total, including Opiant Pharmaceuticals Inc (OPNT) .

Click here to see the complete history of Michael Sinclair’s form 4 insider trades.

Insider Ownership Summary of Michael Sinclair

Ticker Comapny Transaction Date Type of Owner
OPNT Opiant Pharmaceuticals Inc 2022-06-15 director & 10 percent owner & Executive Chairman

Michael Sinclair Latest Holdings Summary

Michael Sinclair currently owns a total of 1 stock. Michael Sinclair owns 19,220 shares of Opiant Pharmaceuticals Inc (OPNT) as of June 15, 2022, with a value of $396,893.

Latest Holdings of Michael Sinclair

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
OPNT Opiant Pharmaceuticals Inc 2022-06-15 19,220 20.65 396,893

Holding Weightings of Michael Sinclair


Michael Sinclair Form 4 Trading Tracker

According to the SEC Form 4 filings, Michael Sinclair has made a total of 6 transactions in Opiant Pharmaceuticals Inc (OPNT) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in Opiant Pharmaceuticals Inc is the sale of 13,616 shares on June 15, 2022, which brought Michael Sinclair around $149,231.

Insider Trading History of Michael Sinclair

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Michael Sinclair Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Michael Sinclair Ownership Network

Ownership Network List of Michael Sinclair

No Data

Ownership Network Relation of Michael Sinclair


Michael Sinclair Owned Company Details

What does Opiant Pharmaceuticals Inc do?

Who are the key executives at Opiant Pharmaceuticals Inc?

Michael Sinclair is the director & 10 percent owner & Executive Chairman of Opiant Pharmaceuticals Inc. Other key executives at Opiant Pharmaceuticals Inc include other: General Counsel Brian Gorman , Chief Scientific Officer Phil Skolnick , and director & 10 percent owner & Chief Executive Officer Roger Crystal .

Opiant Pharmaceuticals Inc (OPNT) Insider Trades Summary

Over the past 18 months, Michael Sinclair made no insider transaction in Opiant Pharmaceuticals Inc (OPNT). Other recent insider transactions involving Opiant Pharmaceuticals Inc (OPNT) include a net sale of 7,570 shares made by Roger Crystal , a net sale of 2,885 shares made by Ellison Mark Jason Heath , and a net sale of 2,556 shares made by David D O'toole .

In summary, during the past 3 months, insiders sold 0 shares of Opiant Pharmaceuticals Inc (OPNT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 17,038 shares of Opiant Pharmaceuticals Inc (OPNT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 17,038 shares.

Opiant Pharmaceuticals Inc (OPNT)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Opiant Pharmaceuticals Inc Insider Transactions

No Available Data

Michael Sinclair Mailing Address

Above is the net worth, insider trading, and ownership report for Michael Sinclair. You might contact Michael Sinclair via mailing address: 86 Gloucester Place, London Xx W1u6hp.

Discussions on Michael Sinclair

No discussions yet.